Home Bristol-Myers Squibb Bristol-Myers Squibb
In operation
Post-IPO Round
Biopharmaceutical and Nutritional Product R&D and Sales
Basic
Enterprise Profile
LinkedIn
Basic Information
Bristol-Myers Squibb Company engages in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of pharmaceuticals and nutritional products through its subsidiaries.The company is divided into two segments: the Pharmaceutical segment and the Nutrition segment. The Pharmaceutical segment consists of global pharmaceuticals and international consumer healthcare businesses. The Nutrition segment operates through the company's subsidiary, Mead Johnson Nutrition Company (Mead Johnson).
Bristol-Myers Squibb Company
NewYork,NewYork,United States of America
more than 500 people
January 01, 1887
--
Enterprise Profile
Industrial Sector
Nutritional Supplement Manufacturing
New Drug Development
Manufacture of Chemical Pharmaceutical Preparations
Manufacture of Biological Pharmaceutical Products
Immune Cell Therapy
Technology
Gene Technology
Targeted Technology
Immunological Techniques
Cell Technology
Protein Technology
Concept
Therapeutic Products
Department of Pharmacy
Ovarian Cancer
Breast Cancer
# Liver Cancer
Lung Cancer
Gastric Cancer
Esophageal Cancer
Lymphoma
Colorectal Cancer
Prostate Cancer
Leukemia
Application Scenarios
Innovative Drugs
Monoclonal Antibody
Bispecific Antibody
ADC (Antibody-Drug Conjugate)
Cell and Gene Therapy
AI+Pharmaceuticals
Novel Coronavirus